drugset / Trial / NCT00815048

Remifentanil and Atropine for Intubation in Neonates

NCT00815048

Phase 4 Completed 30 enrolled King Saud University McMaster University · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The investigators hypothesize that the use of a combination of Atropine and Remifentanil will safely facilitate non emergent intubation procedure as effectively as the protocol of Atropine, Fentanyl, and Succinylcholine.

Timeline

Start
2006-01
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 2 ug/kg
Comparator Remifentanil Small molecule 3 ug/kg
Comparator Suxamethonium Other / unclassified 2 mg/kg
Comparator Atropine Other / unclassified 20 ug/kg

Indications

No indication recorded.